文献速递主动脉疾病

预防性弹簧圈栓塞肠系膜下动脉和腰动脉减少腹主动脉瘤腔内修复术后瘤囊增长及二次干预

Reducing aneurysm sac growth and secondary interventions following endovascular abdominal aortic aneurysm repair by preemptive coil embolization of the inferior mesenteric artery and lumbar arteries.
PubMed 文献 · J Vasc Surg · 2023-11-24

该回顾性队列研究纳入2012年1月至2020年12月连续300例非破裂肾下腹主动脉瘤行EVAR患者,其中99例接受预防性IMA和/或LA栓塞。结果显示预防性栓塞显著降低EVAR后因瘤囊增长需二次干预的需求(92.9% vs 81.5%,P=0.009)。

要点

  • 预防性栓塞IMA和/或LA使EVAR后免于二次干预的比例达92.9%,未栓塞组为81.5%(P=0.009)。
  • 瘤囊增长与EL-2存在显著关联:36例瘤囊增长中27例(75%)伴EL-2,9例(25%)无EL-2(P<0.001)。
  • IMA与L4 LA同时通畅时瘤囊增长发生率最高(17.6%),两者均闭塞时最低(5.3%)(P=0.018)。

核心结论

  • 预防性弹簧圈栓塞IMA和LAs,尤其是L4 LA,可减少因瘤囊增长需二次干预的需求,可能改善EVAR的长期耐久性。

研究设计与样本

  • 回顾性队列研究,纳入2012年1月至2020年12月连续接受EVAR的非破裂肾下腹主动脉瘤患者300例(平均年龄74±8.5岁,男性83.7%),其中99例接受预防性IMA和/或LA栓塞;排除任何I、III或IV型内漏患者。

主要发现

  • 中位随访59.3±30.5个月,36例(12%)出现瘤囊增长,其中12例(33.3%)曾接受预防性栓塞;瘤囊增长检出中位时间28.8个月(IQR 15.2-46.5个月),平均增长10.1±6.4 mm。
  • 瘤囊增长与EL-2显著相关:36例中27例(75%)伴EL-2 vs 9例(25%)无EL-2(P<0.001)。
  • 瘤囊增长患者通畅的下位LAs(L3、L4)平均总数较高(2.6±1.5 vs 2.0±1.4,P=0.03);L1、L2、L3 LA通畅与瘤囊增长无关;至少一支L4 LA通畅与瘤囊增长显著相关(14.8% vs 7.7%,P=0.04)。
  • IMA和L4 LA均通畅时瘤囊增长发生率最高(17.6%),两者均闭塞时最低(5.3%)(P=0.018)。
  • 预防性栓塞IMA和/或LA显著减少EVAR后因瘤囊增长需二次干预:栓塞组99例中92例(92.9%)免于二次干预 vs 未栓塞组201例中163例(81.5%)(P=0.009)。

关键数值与推荐

  • 瘤囊增长定义为随访CTA上中心线轴向直径增加≥5 mm。

临床怎么用

  • 作者认为预防性弹簧圈栓塞IMA和LAs(尤其是L4 LA)可减少因瘤囊增长需二次干预的需求,可能改善EVAR的长期耐久性。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Type II endoleak (EL-2) is the most common complication following endovascular aneurysm repair (EVAR), leading to continued sac growth and potential rupture. In this study, we examined the association between patency of the inferior mesenteric artery (IMA) and lumbar arteries (LAs) with respect to sac growth. The effect of preemptive embolization of the IMA and/or LAs on the need for secondary interventions for sac growth post-EVAR was also evaluated. METHODS: A retrospective cohort study was performed on consecutive patients who underwent EVAR for non-ruptured, infrarenal abdominal aortic aneurysms (AAAs) from January 2012 to December 2020. A select group of patients underwent preemptive embolization of the IMA and/or LA. Patients with any types I, III, or IV endoleaks were excluded. Patency of the IMA and LA on preoperative computed tomography angiogram (CTA) was evaluated on TeraRecon workstation. All secondary interventions to treat EL-2 were recorded. Sac growth was defined as centerline axial diameter increase of ≥5 mm on follow-up CTA. RESULTS: A total of 300 patients (mean age, 74 ± 8.5 years; 83.7% male) underwent EVAR. Ninety-nine patients had preemptive embolization of the IMA and/or LA. Mean follow-up of the cohort was 59.3 ± 30.5 months. Thirty-six patients (12%) demonstrated sac growth on follow-up; 12 of these (33.3%) had preemptive embolization. The median time until detection of sac growth was 28.8 months (interquartile range, 15.2-46.5 months), with a mean growth of 10.1 ± 6.4 mm. Sac growth was significantly associated with presence of EL-2: 27 of 36 (75%) with EL-2 vs 9 of 36 (25%) without EL-2 (P < .001). Patients with sac growth had a higher mean total number (2.6 ± 1.5) of patent lower LAs (L3, L4) compared with those without (2.0 ± 1.4; P = .03). Patency of L1, L2, and L3 LAs were not associated with sac growth. However, patency of at least one L4 LA was significantly associated with sac growth (14.8% vs 7.7%; P = .04). The highest incidence of sac growth (17.6%) was seen when both IMA and L4 LA were patent; significantly different from the lowest incidence (5.3%) when both were occluded preoperatively (P = .018). Preemptive coiling of the IMA and/or LA significantly reduced the need for post-EVAR secondary intervention for sac growth. Freedom from post-EVAR secondary intervention was achieved in 92 of 99 (92.9%) pre-EVAR coiled patients vs 163 of 201 (81.5%) patients who did not undergo pre-EVAR coiling (P = .009). CONCLUSIONS: Preemptive coil embolization of the IMA and LAs, especially L4 LA, reduces the need for secondary interventions for sac growth, potentially improving the long-term durability of EVAR.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Chew DK, Schmelter RA, Tran MT, et al. Reducing aneurysm sac growth and secondary interventions following endovascular abdominal aortic aneurysm repair by preemptive coil embolization of the inferior mesenteric artery and lumbar arteries. J Vasc Surg. 2023. PMID: 38008267. doi:10.1016/j.jvs.2023.11.031

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。